KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Health Robotics today announced an exclusive agreement with Can-Med, a leading IV Solution provider and medical device company in the Republic of Turkey, in order to safely, accurately, and cost-effectively automate the preparation of life-critical patient-specific Oncology IV Admixtures with Health Robotics’ CytoCare™. With its CytoCare™ Robot, Health Robotics has developed and deployed the world’s first and only totally automated system for safe preparation of patient-specific Oncology IV doses in Europe, the United States of America, Asia-Pacific, and the Middle East. While other companies have for years made promises of robotic automation products in this area and showcased marketing demonstrations of competing solutions that were supposed to exist as far back as five years ago, the fact remains that CytoCare™ is the only available solution that currently exists anywhere in the world to automatically compound and prepare hazardous and non-hazardous Oncology IV doses, and that has been proven in a “live” hospital environment.
